1. Introduction
Robert R. Wilson was the first scientist to propose particle therapy: the use of particle beams for the treatment of cancer [
[1]Radiological use of fast protons.
]. Today, particle therapy (PT) has become a well established option for tumour treatments, next to surgery, chemotherapy, conventional radiotherapy and emerging immunotherapy. More than one hundred facilities all over the world can provide beams of protons, carbon, or other ions for clinical treatments [
] and tens of therapy centres are now under construction [
].
It is known that ions produce a characteristic dose distribution with a maximum, called the Bragg peak (BP), followed by a steep dose fall-off, when they interact with matter. The opportunity to have such a step in the dose distribution is the main advantage of charged particles over photons, so that it allows to precisely hit the tumour site, sparing deeper normal tissues. Moreover, tissues located upstream of the BP also get smaller dose than in conventional therapy. However, the intrinsic precision of charged hadrons can be a double-edged sword, as particle range is not exempted from uncertainties, which are closely related to the imperfect knowledge on the patient morphology (see [
4Range uncertainties in proton therapy and the role of Monte Carlo simulations.
,
5- Paganetti H.
- Beltran C.
- Both S.
- Dong L.
- Flanz J.
- et al.
Roadmap: Proton therapy physics and biology.
] for an extensive discussion on range uncertainties). For this reason, if the BP position is mislocated with respect to the treatment plan, it can result in a non-effective treatment of the pathology, putting in danger nearby normal tissues, therefore making the advantageous feature of hadrontherapy not fully exploitable.
Due to range uncertainties, safety margins are applied in the treatment planning and this limits the full benefits of PT. To improve precision and restrain normal tissue irradiation, range uncertainties must be reduced. Thus, efforts have been made to develop instruments aiming at the precision of a few mm or better in verifying the particle range
in-vivo [
[6]On-and off-line monitoring of ion beam treatment.
].
Different approaches have been investigated to reduce range uncertainty through
in-vivo range verification. They can be classified in direct methods, based on direct measurement of the depth-dose distribution, and indirect methods, which take advantage of the secondary emission from the patient during treatment. A general comparison and overview of the techniques used for
in-vivo proton range verification are summarized in various review articles [
7In Vivo proton range verification: A review.
,
8- Krimmer J.
- Dauvergne D.
- Létang J.
- Testa É.
Prompt-gamma monitoring in hadrontherapy: A review.
].
Online control of the particle range can be performed by means of secondary radiations emitted from nuclear reactions, following the interaction of the primary ion beam with human tissues [
[6]On-and off-line monitoring of ion beam treatment.
]. Indeed, for some types of secondary radiation, there exists a correlation between the secondary emission and the depth-dose distribution, so that different techniques have been developed in order to monitor the particle range. In-beam Positron Emission Tomography (PET) has been already applied clinically at GSI [
[9]- Enghardt W.
- Crespo P.
- Fiedler F.
- Hinz R.
- Parodi K.
- et al.
Charged hadron tumour therapy monitoring by means of PET.
] and at CNAO [
[10]- Bisogni M.G.
- Attili A.
- Battistoni G.
- Belcari N.
- Cerello P.
- et al.
INSIDE in-beam positron emission tomography system for particle range monitoring in hadrontherapy.
]. The detection of secondary charged particles, as protons in carbon beam irradiation, has been also adopted in inter–fractional monitoring in clinical trials [
[11]- Fischetti M.
- Baroni G.
- Battistoni G.
- Bisogni G.
- Cerello P.
- et al.
Inter-fractional monitoring of c ions treatments: Results from a clinical trial at the CNAO facility.
]. Prompt emission of high-energy gamma rays provides a more direct and instantaneous signature of the beam range in matter [
[12]Stichelbaut F, Jongen Y. Verification of the proton beam position in the patient by the detection of prompt gamma-rays emission. In: 39th meeting of the particle therapy co-operative group, Vol. 16. 2003.
]. The use of prompt-gamma (PG) detection to monitor proton range has been already experimentally verified (e.g., [
13- Min C.-H.
- Kim C.H.
- Youn M.-Y.
- Kim J.-W.
Prompt gamma measurements for locating the dose falloff region in the proton therapy.
,
14- Kelleter L.
- Wrońska A.
- Besuglow J.
- Konefał A.
- Laihem K.
- et al.
Spectroscopic study of prompt-gamma emission for range verification in proton therapy.
]). A Prompt Gamma Imaging (PGI) knife-edge camera, developed by IBA in collaboration with Politecnico di Milano and XGLab [
[15]- Perali I.
- Celani A.
- Bombelli L.
- Fiorini C.
- Camera F.
- et al.
Prompt gamma imaging of proton pencil beams at clinical dose rate.
], has been applied for the first time clinically for a treatment of a head and neck tumour [
[16]- Richter C.
- Pausch G.
- Barczyk S.
- Priegnitz M.
- Keitz I.
- et al.
First clinical application of a prompt gamma based in Vivo proton range verification system.
], with measured inter-fractional global range variations in the order of
. A second prototype of prompt gamma camera utilizing a knife-edge collimator design was tested, as reported in [
[17]- Xie Y.
- Bentefour E.H.
- Janssens G.
- Smeets J.
- Vander Stappen F.
- et al.
Prompt gamma imaging for in Vivo range verification of pencil beam scanning proton therapy.
]. Developments of Compton cameras for PG measurements are also ongoing (see, e.g., [
18- Draeger E.
- Mackin D.
- Peterson S.
- Chen H.
- Avery S.
- et al.
3D prompt gamma imaging for proton beam range verification.
,
19- Fontana M.
- Ley J.-L.
- Dauvergne D.
- Freud N.
- Krimmer J.
- et al.
Monitoring ion beam therapy with a compton camera: Simulation studies of the clinical feasibility.
,
20- Kasper J.
- Rusiecka K.
- Hetzel R.
- Kozani M.K.
- Lalik R.
- et al.
The SiFi-CC project - feasibility study of a scintillation-fiber-based compton camera for proton therapy monitoring.
]) although not yet with clinical trials. Prompt-gamma spectroscopy (PGS) [
21- Verburg J.M.
- Shih H.A.
- Seco J.
Simulation of prompt gamma-ray emission during proton radiotherapy.
,
22Proton range verification through prompt gamma-ray spectroscopy.
] and timing (PGT) [
[23]- Golnik C.
- Hueso-González F.
- Müller A.
- Dendooven P.
- Enghardt W.
- et al.
Range assessment in particle therapy based on prompt -ray timing measurements.
], based respectively on energy and timing (time-of-flight) measurements, are also under development and have been recently tested [
24- Dal Bello R.
- Magalhaes Martins P.
- Graça J.
- Hermann G.
- Kihm T.
- et al.
Results from the experimental evaluation of CeBr scintillators for He prompt gamma spectroscopy.
,
25- Werner T.
- Berthold J.
- Hueso-González F.
- Koegler T.
- Petzoldt J.
- et al.
Processing of prompt gamma-ray timing data for proton range measurements at a clinical beam delivery.
,
26- Magalhaes Martins P.
- Dal Bello R.
- Seimetz M.
- Hermann G.
- Kihm T.
- et al.
A single-particle trigger for time-of-flight measurements in prompt-gamma imaging.
,
27- Hueso-González F.
- Rabe M.
- Ruggieri T.A.
- Bortfeld T.
- Verburg J.M.
A full-scale clinical prototype for proton range verification using prompt gamma-ray spectroscopy.
].
In recent years, there has been a substantial progress in the application of PGI mostly for what concerns proton therapy. On the other hand, fewer studies have been made in the use of PGI verification within Carbon Ion Radiation Therapy (CIRT). Indeed, even if there are undoubted advantages of C-ion over proton and photon therapy [
[28]- Malouff T.D.
- Mahajan A.
- Krishnan S.
- Beltran C.
- Seneviratne D.S.
- et al.
Carbon ion therapy: A modern review of an emerging technology.
], it is also true that the very same factors that make C-ions such interesting may hinder the application of PGI monitoring. For example, although C-ions have a higher prompt gamma yield with respect to protons [
29- Pinto M.
- De Rydt M.
- Dauvergne D.
- Dedes G.
- Freud N.
- et al.
Experimental carbon ion range verification in inhomogeneous phantoms using prompt gammas.
,
30- Zarifi M.
- Guatelli S.
- Qi Y.
- Bolst D.
- Prokopovich D.
- et al.
Characterization of prompt gamma ray emission for in Vivo range verification in particle therapy: A simulation study.
], they also have a higher neutron yield. In addition to this, for ions heavier than protons, the number of incident projectiles needed to provide a given physical dose is littler than for protons, due to the
dependence of energy loss (Z being the atomic number) and the smaller mean multiple scattering angle of heavier ions. Moreover, the Relative Biological Effectiveness (RBE) leads to a further reduction of the number of ions necessary to deliver the desired biological dose with higher-Z ions. Therefore, the total number of generated PGs for a given pencil beam spot is lower when considering heavier ions, strongly affecting their counting statistics [
[31]Range verification by means of prompt-Gamma detection in particle therapy 1.
]. The aforementioned factors make the optimization of detection efficiency and gamma-neutron discrimination even more critical for the application of PGI to CIRT. So far, Time-of-flight (TOF) discrimination technique has been successfully applied to the observation of PGs in carbon ion irradiation [
[32]- Testa E.
- Bajard M.
- Chevallier M.
- Dauvergne D.
- Le Foulher F.
- Freud N.
- et al.
Monitoring the bragg peak location of 73 MeV/u carbon ions by means of prompt -ray measurements.
].
Monte-Carlo simulations play not only a crucial role in the design and optimization of detection systems, including those dedicated for PGI, but also in techniques for range shift detection. GEANT4 is the most used framework dedicated to this field, even if modifications to PG emission modelling in newer software versions have shown to increase the discrepancy between the simulation results and the experimental data [
[33]- Wrońska A.
- Kasper J.
- Ahmed A.A.
- Andres A.
- Bednarczyk P.
- et al.
Prompt-gamma emission in GEANT4 revisited and confronted with experiment.
]. On the other hand, the FLUKA simulation tool has been also used to reproduce the PG emission and good agreement was found both in the spectrum shape, and in the energy-integrated PG depth profile [
[34]- Battistoni G.
- Bauer J.
- Boehlen T.T.
- Cerutti F.
- Chin M.P.
- et al.
The FLUKA code: An accurate simulation tool for particle therapy.
]. A feasibility study in the literature for the use of a pixelated slit camera in CIRT was performed by Smeets [
[35]Prompt gamma imaging with a slit camera for real time range control in particle therapy.
]. The results of the Monte Carlo (MC) simulations showed a weak correlation between PG and BP profiles. Anyway, the author himself questioned whether the MC code he used (MCNPX version 2.7.E) was mature enough for the simulation of prompt gamma emission during carbon ion irradiation at clinical energies. Hence, we decided to take the precious legacy of the work conducted by Smeets and, in the present work, we investigated whether with updated Physics models inside the general purpose FLUKA MC code results come out differently. We thus conducted a numerical study to explore the feasibility of using a knife-edge slit prompt-gamma camera with a beam of C-ions at clinical energies. Firstly, we simulated the response of the detector to the delivery of a single pencil beam spot to a uniform soft-tissue phantom. In the second part of the study, we examined the cumulative signal obtained from the delivery of multiple spots within the same transversal layer, seeking the chance to still reconstruct the position of the BP. The final goal of this work is to explore the PG fall-off retrieval capability with a well-established slit camera configuration, already tested clinically with proton irradiation [
[16]- Richter C.
- Pausch G.
- Barczyk S.
- Priegnitz M.
- Keitz I.
- et al.
First clinical application of a prompt gamma based in Vivo proton range verification system.
].
4. Discussion
Results about PGI fall-off determination for different numbers of C-ions incident on a soft-tissue phantom have been obtained using MC simulations with the FLUKA code, which is now considered a reliable tool for simulations in hadrontherapy, both for the prediction of dose delivery and PG emission [
[34]- Battistoni G.
- Bauer J.
- Boehlen T.T.
- Cerutti F.
- Chin M.P.
- et al.
The FLUKA code: An accurate simulation tool for particle therapy.
]. The most recent FLUKA models for PG production showed a good reproduction of the relative shapes of experimental photon profiles as a function of depth as well as the absolute photon yield per primary C-ion, with an accuracy of about 15%–20%.
MC simulations showed that, for the beam energy and the detection system of interest, the signal profile due to the secondary particles emitted from the delivery of a single spot to the phantom was correlated with the BP. Moreover, we demonstrated that the shape of the profile was clearly determined by the prompt-gamma signal over an almost uniform neutron background. To probe the theoretical limitations of our gamma camera, we numerically reproduced an experiment for the measurement of the sensitivity in particle range retrieval. The reference curves for 2 mm shifts of the phantom were clearly distinguishable, opening the possibility to detect 2 mm shifts of the BP with a sufficiently high number of incident ions. Indeed, in accordance with Krimmer et al. [
[8]- Krimmer J.
- Dauvergne D.
- Létang J.
- Testa É.
Prompt-gamma monitoring in hadrontherapy: A review.
], we obtained that the accuracy of the system in range retrieval scales with the number of incident ions
Ni as
1/
. However, the number of ions delivered in a single spot has proved to be too small for reaching that level of precision. From the trend-line of data fitting, we found that at least around
particles were needed to go below a 2 mm accuracy with the present setup, without considering sources of experimental error or factors that may affect the detection efficiency in a real detection system. For instance, the main factor we expect is the dead time of the readout electronics and data acquisition system which, in case of high rates, may limit the counting efficiency and linearity of the detector response. Thus, we do not expect this technique to be effective on a spot-by-spot basis due to the low counting statistics of prompt-gammas, at least in the considered knife-edge configuration. However, different improvements could be introduced to increase the detection efficiency of the camera. For example, a first step could be to enhance the geometrical acceptance by using multiple cameras. Then, the intrinsic efficiency of the detector could be improved by removing the mechanical collimator, as under study in the development of Compton Cameras. Nonetheless,
particles is actually the maximum amount used in an irradiation spill at CNAO (see [
[41]Operation and patient treatments at CNAO facility.
]), delivered by their synchrotron to cover a given layer of the tumour volume. Thus, we proceeded to verify whether the distal position of the beam in an energy layer could be retrieved with a good accuracy. For this, we used
ions, i.e., the average number of particles in a spill according to the interval found in [
[41]Operation and patient treatments at CNAO facility.
]. Consequently, we combined the PGs signals obtained from 9 spots covering a 2 × 2 cm
2 area, assuming that the
ions were divided equally among the selected spots. We found that a 4 mm accuracy is achievable with the present camera. Even introducing a
beam range variation within the same layer by tilting the phantom (see Section
2.4), the accuracy was not worsened.
Although our results suggested that range verification on a spot-by-spot basis seems not to be feasible, it may be worth to further investigate PGI technique for CIRT, at least on the single spill basis. Even though a layer-by-layer approach in range verification is not strictly a real-time technique, it could still be useful to reduce the uncertainties during the treatment and also for post-treatment verification. Differently, having in mind that our results were dominated by the counting statistics, for the number of C-ions used in a single spot of FLASH therapy, there could be a chance to use real-time PGI during a FLASH therapy treatment. Finally, the conclusions drawn in the present work will be tested in a future experimental campaign we are currently organizing.
We would like here also to highlight some limitations of our study. First of all, our simulations did not consider additional sources of neutron background, like the contribution of scattered neutrons from walls in the room. However, simulations performed including a 2 m thick spherical concrete wall with a 4 m inner radius did not show a significant loss of accuracy in range retrieval. Regarding the selected beam energy, a higher neutron background is expected for irradiation at higher ion energies, which could affect the capability to distinguish a PG fall-off. Therefore, future simulation studies will be necessary to explore the feasibility in the whole interval of therapeutic energies and, for the upper part of such interval, an additional effort to adopt gamma-neutron discrimination techniques might be useful and decisive.
Concerning the detector signal, we did not include the coupling between the scintillator and the readout system, which may reduce the detection efficiency, for instance due to count rate limits. Moreover, a 4 keV energy resolution was assumed for the detector, which is much better than the one of the real system, but having considered the events in an energy range of
, we do not expect this to play a critical role. Finally, in this work we have considered only a homogeneous phantom. Therefore, further studies with inhomogeneities in the composition of the phantom should be carried out, in order to compare the results with the accuracy found in the homogeneous case. Regarding this topic, some ideas were elaborated for proton therapy, which could be inspiring for the same aim in CIRT (see [
27- Hueso-González F.
- Rabe M.
- Ruggieri T.A.
- Bortfeld T.
- Verburg J.M.
A full-scale clinical prototype for proton range verification using prompt gamma-ray spectroscopy.
,
44- Priegnitz M.
- Helmbrecht S.
- Janssens G.
- Perali I.
- Smeets J.
- et al.
Measurement of prompt gamma profiles in inhomogeneous targets with a knife-edge slit camera during proton irradiation.
]).
Article info
Publication history
Published online: March 10, 2023
Accepted:
February 18,
2023
Received in revised form:
February 9,
2023
Received:
July 3,
2022
Copyright
© 2023 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.